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Background: Methicillin-resistant Staphylococcus aureus (MRSA) has been responsible for 
serious hospital infections worldwide. Nanomaterials are an alternative to conventional antibiotic 
compounds, because bacteria are unlikely to develop microbial resistance against nanomaterials. 
In the past decade, graphene oxide (GO) has emerged as a material that is often used to support 
and stabilize silver nanoparticles (AgNPs) for the preparation of novel antibacterial nanocompos-
ites. In this work, we report the synthesis of the graphene-oxide silver nanocomposite (GO-Ag) 
and its antibacterial activity against relevant microorganisms in medicine.
Materials and methods: GO-Ag nanocomposite was synthesized through the reduction of 
silver ions (Ag+) by sodium citrate in an aqueous GO dispersion, and was extensively charac-
terized using ultraviolet-visible absorption spectroscopy, X-ray diffraction, thermogravimetric 
analysis, X-ray photoelectron spectroscopy, and transmission electron microscopy. The antibacte-
rial activity was evaluated by microdilution assays and time-kill experiments. The morphology 
of bacterial cells treated with GO-Ag was investigated via transmission electron microscopy.
Results: AgNPs were well distributed throughout GO sheets, with an average size of 9.4±2.8 nm. 
The GO-Ag nanocomposite exhibited an excellent antibacterial activity against methicillin-
resistant S. aureus, Acinetobacter baumannii, Enterococcus faecalis, and Escherichia coli. All 
(100%) MRSA cells were inactivated after 4 hours of exposure to GO-Ag sheets. In addition, 
no toxicity was found for either pristine GO or bare AgNPs within the tested concentration 
range. Transmission electronic microscopy images offered insights into how GO-Ag nanosheets 
interacted with bacterial cells. 
Conclusion: Our results indicate that the GO-Ag nanocomposite is a promising antibacterial 
agent against common nosocomial bacteria, particularly antibiotic-resistant MRSA. Morpho-
logical injuries on MRSA cells revealed a likely loss of viability as a result of the direct contact 
between bacteria and the GO-Ag sheets.
Keywords: graphene oxide, silver nanoparticles, graphene oxide-silver nanocomposite, 
antibacterial agent, MRSA, Escherichia coli 
Introduction
Antibiotic-resistant microorganisms are a growing global concern. In particular, 
methicillin-resistant Staphylococcus aureus (MRSA) has overcome a variety of 
antibiotics in the past few decades, and its dissemination has led to serious hospital-
acquired infections worldwide.1,2 MRSA can easily spread in hospitals, health care 
facilities, and community environments. Transmission of the microbe occurs mostly 
through direct contact with wounds, respiratory and feeding tubes, urinary catheters, 
and indwelling devices.3
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According to the World Health Organization (WHO), 
approximately 5%–10% of patients throughout the world 
will face some acquired nosocomial infection during 
hospitalization.4 The US Centers for Disease Control and 
Prevention has estimated that in the US alone, the mortality 
rate due to infections may reach 3.1 deaths for every 9.7 
hospitalized patients.5 In Latin America, including countries 
such as Brazil and Argentina, the incidence of MRSA has 
reached 67% of all S. aureus-related infections.6 
MRSA is especially resistant toward β-lactam antibiot-
ics (penicillin, cephalosporin, and carbapenems),7 and its 
drug-resistance mechanism is mediated by the production 
of β-lactamase enzymes and the mecA gene, which encodes 
the penicillin-binding protein PBP2a.8 These infections cost 
health care systems billions of dollars, and there is an expec-
tation that the number of infections will continuously increase 
over the years.9 Thus, the emergence of antibiotic-resistant 
bacteria represents a serious problem that could be overcome 
by the development of novel antimicrobial agents.
Nanomaterials are an alternative approach to treating and 
mitigating infections caused by resistant bacteria. Microbial 
cells are unlikely to develop resistance to nanomaterials, 
because they exert toxicity through different mechanisms 
than conventional antibiotics. Antimicrobial nanomaterials 
such as zinc oxide, titanium oxide, and single-walled carbon 
nanotubes may offer several advantages due to their unique 
physicochemical properties and high surface areas.10 Specifi-
cally, graphene oxide (GO) sheets are composed of oxidized 
graphene sheets bearing oxygen-containing functional groups 
such as epoxy, carboxyl, carbonyl, and hydroxyl groups. 
GO is highly hydrophilic, yields stable dispersions in water, 
and can be easily produced on a large scale. In addition, 
the oxygenated groups enable the straightforward chemical 
functionalization of GO sheets via covalent and non-covalent 
interactions.11 Graphene has been extensively used for sev-
eral biological applications including bioimaging,12 tissue 
engineering,13 drug delivery,14 and regenerative medicine.15 
Furthermore, the effects of graphene on mammalian stem,16 
cancerous,17 and bacterial cells18 have been explored.
Graphene-based nanomaterials have drawn much atten-
tion as excellent platforms to which silver nanoparticles 
(AgNPs) can be anchored for the production of antimicrobial 
nanocomposites.19–25 AgNPs are widely known because of 
their outstanding antimicrobial toxicity in comparison to 
their bulk counterparts.26 However, AgNPs present a strong 
tendency to aggregate in aqueous solutions, leading to a 
decrease in biocidal activity.26 Although the use of surfactants 
can maintain the colloidal stability of AgNPs, they can also 
hinder the particles’ surface oxidation. As a consequence, 
a reduced toxicity to bacterial cells might be observed as a 
result of the decreased rate of Ag+ ion release.27 Therefore, 
these distinct and attractive features make GO an appealing 
platform for building novel antibacterial nanocomposites. 
GO sheets act as support layers to stabilize and to prevent 
AgNPs from aggregating, allowing a more controlled release 
of Ag+ ions and an enhanced antimicrobial activity.
In the current study, we demonstrated the synthesis of 
GO-silver nanocomposite (GO-Ag) through the reduction 
of Ag+ ions by sodium citrate (Na
3
C
6
H
5
O
7
) in an aqueous 
GO dispersion. These nanocomposites exhibited a broad-
spectrum of antibacterial activity and a noticeable toxicity 
to antibiotic-resistant MRSA. We also investigated the 
interaction between GO-Ag sheets and bacterial cells via 
transmission electron microscopy (TEM). To the best of 
our knowledge, this is the first report providing evidence of 
how GO-Ag nanocomposites interact with MRSA cells. Our 
results indicate that GO-Ag nanocomposites are promising 
antibacterial agents. These nanocomposites may possibly be 
used as a platform for the development of novel materials 
that are able to mitigate microbial proliferation in biomedical 
devices and hospital facilities.
Materials and methods
Materials and chemicals
Natural graphite powder (98.0%) was purchased from 
Synth (Diadema, Brazil) and was used as received. Potas-
sium permanganate (KMnO
4
, 99.0%), sulfuric acid (H
2
SO
4
, 
95.0%–98.0%), hydrochloric acid (HCl, 36.5%–38.0%), 
hydrogen peroxide (H
2
O
2
, 30.0%), and Na
3
C
6
H
5
O
7
 (99.0%) 
were also obtained from Synth. Phosphorous pentoxide 
(P
2
O
5
, 98.0%), potassium persulfate (K
2
S
2
O
8
, 99.0%), and 
silver nitrate (AgNO
3
, $99.0%) were provided by Sigma-
Aldrich Co (St Louis, MO, USA). The Mueller-Hinton 
medium for bacterial cultivation was purchased from Becton, 
Dickinson and Company (Franklin Lakes, NJ, USA). The 
deionized (DI) water used in all experiments was supplied 
by a Milli-Q® purification system (EMD Millipore, Billerica, 
MA, USA). All chemicals were analytical grade.
synthesis of gO
Single-layered GO sheets were synthesized by the modi-
fied Hummers’ method.28 Briefly, graphite was pretreated 
to ensure complete oxidation. Natural graphite powder 
(1.0 g) was placed into an 80°C solution of concentrated 
H
2
SO
4 
(4.4 mL), K
2
S
2
O
8
 (0.8 g) and P
2
O
5
 (0.8 g). The dark 
blue mixture was kept on a hotplate under magnetic stirring 
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for 4.5 hours. Shortly afterward, heating was stopped, and 
the mixture was diluted with DI water (170 mL) and was 
left overnight. On the following day, the mixture was fil-
tered using a 0.22 µm polyvinylidene fluoride membrane 
(Millipore®; EMD Millipore) and was washed with DI water 
until the filtrate reached neutral pH. The dark, isolated solid 
was dried in air overnight at room temperature.
For the oxidation procedure, the pretreated graphite was 
added slowly into a chilled flask at 0°C containing concen-
trated H
2
SO
4
 (40 mL). KMnO
4
 (5.0 g) was gradually added 
over 15–20 minutes, and the temperature was controlled to 
not exceed 10°C. The ice bath was removed, and the resultant 
dark brown–purple mixture was allowed to react at 35°C for 2 
hours. DI water (77 mL) was then added in small aliquots, and 
an ice bath was used to maintain the temperature below 50°C. 
After the water addition, the mixture was kept under continu-
ous stirring for an additional 2 hours. At that point, more DI 
water (230 mL) was introduced into the flask. Immediately 
afterward, 30% H
2
O
2
 (4 mL) was added, resulting in a bright 
yellow mixture that was allowed to settle for 2 days. The mix-
ture was decanted, and the clear supernatant was removed. 
The remaining mixture was purified by centrifugation and 
was washed with 10% HCl (500 mL), followed by DI water, 
to remove metal ions and acid, respectively. The product was 
then suspended in DI water to give a stable, viscous brown 
dispersion, which was dialyzed for 10 days to remove residual 
salts (Fisherbrand™ dialysis tubing, 12,000–14,000 Da; 
Thermo Fisher Scientific, Waltham, MA, USA). The resulting 
homogeneous graphite oxide dispersion was lyophilized and 
was stored in a sealed vessel. GO suspensions were obtained 
by dispersing the product in water followed by sonication in 
an ultrasound bath (Cole-Parmer 8891).
synthesis of gO-ag
GO sheets were functionalized with AgNPs using a modified 
Turkevich method.19,29 For this procedure, a colloidal disper-
sion of GO was prepared by dispersing 6.25 mg of GO in 
20 mL of DI water followed by sonication in an ultrasound 
bath for 30 minutes. Next, 8.4 mg of AgNO
3
 was dissolved 
in 20 mL DI water and then mixed with the previous GO 
dispersion. This mixture was sonicated for an additional 
30 minutes and was transferred to a two-neck round-bottom 
flask. The AgNPs were produced using Na
3
C
6
H
5
O
7
 as a 
reducing agent. The dispersion containing GO and AgNO
3
 
was heated at reflux, and as soon as it began to boil, 10 mL of 
a 1.0×10-3 mol L-1 Na
3
C
6
H
5
O
7
 solution was added dropwise. 
The reaction was maintained for 50 min at 130°C. The color 
of the solution slowly turned black–green, indicating the 
formation of the GO-Ag nanocomposite. The GO-Ag was 
dialyzed for 2 days to remove residual salts (Fisherbrand 
dialysis tubing 12,000–14,000 Da) and stored in a sealed 
vessel protected from light.
characterization of gO and gO-ag
The physicochemical characterization of GO and GO-Ag 
was performed using several techniques. Primarily, ultra-
violet-visible (UV-vis) spectroscopy was carried out using 
a Shimadzu UV-1650PC spectrometer. X-ray diffraction 
(XRD) analysis was conducted using a Shimadzu XRD-700 
diffractometer with CuΚα X-ray radiation (λ=1.54056 Å, 
40 kV, 5° ,2θ, ,80° with a scan rate of 2° min-1). Ther-
mogravimetric analysis (TGA) was performed using a 
thermogravimetric analyzer (SDTQ600; TA Instruments, 
New Castle, DE, USA; 10°C min-1, synthetic air flow rate 
of 100 mL min-1). X-ray photoelectron spectroscopy (XPS) 
spectra were obtained using a Κ-Alpha X-ray photoelectron 
spectrometer (Thermo Fisher Scientific). Fourier transform 
infrared spectroscopy (FTIR) spectra were recorded using 
an MB B100 spectrometer (ASEA Brown Boveri, Zürich, 
Switzerland; potassium bromide pellet). Raman spectroscopy 
measurements were performed on a T64000 (Horiba, Kyoto, 
Japan) with an argon ion laser set to an excitation wavelength 
of 514 nm. The morphology of GO and GO-Ag nanocompos-
ite was observed by TEM (LIBRA 120, accelerating voltage 
of 120 kV; Zeiss International, Oberkochen, Germany). 
evaluation of antibacterial activity
The antibacterial activity of GO and GO-Ag was evaluated 
by microdilution assays, as described by the Clinical and 
Laboratory Standards Institute (CLSI).30 To determine the 
minimal inhibitory concentration (MIC) and minimal bacte-
ricidal concentration (MBC), Gram-positive strains includ-
ing S. aureus N315 (MRSA), kindly provided by Professor 
Dr Keiichi Hiramatsu (Department of Bacteriology, Faculty 
of Medicine, Juntendo University, Tokyo, Japan);31 S. aureus 
ATCC 29213 (standard CLSI); Enterococcus faecalis (ATCC 
29212); the Gram-negative strains Escherichia coli (ATCC 
25922) and Acinetobacter baumannii (ATCC 19606), both 
kindly provided by the Oswaldo Cruz Foundation (Fiocruz, 
Rio de Janeiro, Brazil); Salmonella enterica Typhimurium 
LT2 (kindly provided by Professor Dr Roy Curtiss III, the 
Biodesign Institute, Arizona State University, Tempe, AZ, 
USA); and Pseudomonas aeruginosa (ATCC 27853) were 
used as model microorganisms.
For the MIC determination, the strains were cultivated in 
Mueller-Hinton agar plates incubated at 37°C for 24 hours 
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to obtain isolated colonies. The cells were suspended in a 
saline solution (NaCl, 0.85% w/v), and the optical density 
(OD
600 nm
) of the suspension was adjusted to 0.5, accord-
ing to the McFarland scale (1.5×108 colony-forming units 
per milliliter [CFU mL-1]). The bacterial suspensions were 
diluted with Mueller-Hinton broth and were distributed in 
a 96-well plate to reach a cellular concentration of 1.0×105 
CFU/well. Each well was exposed to different concentrations 
of GO and GO-Ag nanomaterials (from 60 to 1.0 µg mL-1). 
The plates were incubated at 37°C, and the bacterial growth 
was observed after 18 hours. The MIC was considered as the 
lowest nanomaterial concentration where no bacterial growth 
was visualized. To determine the MBC values, the well plates 
were incubated under identical conditions for 24 hours. Then, 
the bacterial suspension in each well was collected and was 
plated on Mueller-Hinton Petri dishes. The Mueller-Hinton 
agar plates were incubated at 37°C, and the bacterial growth 
was observed after 24 hours.
Time-kill curves experiment
To evaluate the antibacterial activity of GO-Ag nanocompos-
ite as a function of time, we carried out time-kill experiments. 
MRSA and E. coli ATCC 25922 (standard CLSI) were used 
as model microorganisms. The cultivation of bacteria was 
performed as previously described in Evaluation of anti-
bacterial activity section. MRSA and E. coli were exposed 
to GO-Ag concentrations at their MICs, which were both 
equivalent to 15 µg mL-1. The bacterial suspensions were 
then incubated in a rotatory shaker at 37°C and 200 rpm. A 
100 µL aliquot of the bacterial suspension was withdrawn 
from each cavity at different incubation times (0, 2, 4, 6, 8, 
10, 12, and 24 hours) and was serially diluted (1:10) in saline 
solution (0.85% w/v). Next, 25 µL of the diluted samples 
were plated on Mueller-Hinton media and incubated at 37°C 
for 12 hours. The number of bacterial colonies was counted 
and expressed in CFU mL-1. A control was carried out 
without the addition of the biocidal GO-Ag nanocomposite. 
Another control was performed using the GO sample at the 
same concentration used for the GO-Ag nanocomposite. All 
the tests were carried out in triplicate.
TeM imaging of E. coli and Mrsa cells  
after treatment with gO-ag 
nanocomposite
Initially, bacterial cultivation was conducted as described 
in the “Evaluation of antibacterial activity” section. The 
bacterial suspensions were diluted in Mueller-Hinton broth 
to a density of 1.0×105 CFU mL-1 and were incubated for 
3 hours. Then, each strain was treated with GO-Ag nanocom-
posite at the MIC concentration (15 µg mL-1) for 2 hours. 
Negative controls were carried out without the addition of 
GO-Ag (untreated samples). An hour later, the suspensions 
were centrifuged for 10 minutes, and bacterial cells were 
collected and fixed with 3% glutaraldehyde solution (pH 7.4) 
for 2 hours. The samples were centrifuged once more, and 
the cell pellets were washed three times with 0.1 mol L-1 
phosphate-buffered saline (PBS, pH 7.4) solution. The cells 
were fixed with 1% osmium tetroxide (OsO
4
) for 1 hour, and 
then washed twice with a PBS solution. After fixation, the 
cells were concentrated by centrifugation and treated with a 
few drops of a 1.5% agarose solution. Subsequently, the cells 
were dehydrated with ethanol at increasing concentrations: 
50%, 70%, and 90% for 15 minutes each. To remove the 
residual ethanol, the cell pellet was treated initially with a 
mixture of ethanol/polypropylene oxide (1:1) for 15 minutes, 
followed by pure polypropylene oxide for 15 minutes, poly-
propylene oxide/resin (1:1) for 4 hours, and pure epoxy resin 
(Epon Resin 812; Electron Microscopy Sciences, Hatfield, 
PA, USA) overnight. 
The cells were embedded in epoxy resin for 72 hours and 
were placed in an oven for polymerization. After material 
trimming, ultrathin sections were cut using an ultramicro-
tome (Leica Ultracut UCT; Leica Microsystems, Wetzlar, 
Germany). The sections were stained with 4% uranyl acetate 
for 30 minutes and 0.3% lead citrate for 3 minutes and were 
then transferred to uncoated copper grids and examined in a 
Zeiss LEO 902 transmission electron microscope (Zeiss Inter-
national) operating at an accelerating voltage of 60 kV.
Results
Physicochemical characteristics of gO 
and gO-ag nanocomposite
GO-Ag nanocomposite was prepared using Na
3
C
6
H
5
O
7
 as 
a reducing agent. The resulting stable GO-Ag dispersion 
presented a black–green color (Figure 1A). The UV-vis 
spectrum of pristine GO exhibited characteristic bands, with 
a maximum absorption band at approximately 230 nm and a 
shoulder at ~301 nm, corresponding to π-π* electronic transi-
tions of C=C aromatic bonds and n-π* electronic transitions 
of C=O bonds, respectively (Figure 1B). The attachment of 
AgNPs to the GO surface was confirmed primarily through 
the detection of a band at 410 nm, which was attributed to the 
plasmon resonance of AgNPs.20 Moreover, the GO-Ag UV-
vis spectrum showed that the electronic transitions of C=C 
aromatic bonds red-shifted to approximately 263 nm, and that 
the shoulder had disappeared. These observations suggest that 
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GO sheets were simultaneously reduced by Na
3
C
6
H
5
O
7
 during 
the formation of the AgNPs, resulting in a partial restoration 
of π-conjugation within the graphene sheets.32
The attachment of AgNPs to the GO sheet surface was 
also evaluated by XRD patterns (Figure 1C). The GO-Ag dif-
fraction peaks observed at 2θ =38.1°, 44.3°, 64.5°, and 77.5° 
matched the crystalline planes of face-centered cubic silver 
(Joint Committee on Powder Diffraction Standards [JCPDS] 
card number 07-0783).33 Moreover, the peak at 2θ =10.5° 
that is usually attributed to the stacking of GO sheets dis-
appeared after decoration with the AgNPs. Therefore, the 
functionalization of the GO surface with the AgNPs might 
prevent the graphene sheets from restacking.34
The TGA of both nanomaterials displayed a two-step 
decomposition behavior (Figure 1D). The first mass loss in 
the range of 150°C–210°C was attributed to the decomposi-
tion of oxygenated functional groups. The second decomposi-
tion step was ascribed to the decomposition of the graphitic 
portion. Interestingly, the GO-Ag nanocomposite showed 
a reduction in thermal decomposition temperatures for the 
second mass loss step, which occurred approximately 200°C 
earlier in comparison to the GO sample. This phenomenon 
suggested that AgNPs catalyze the material combustion, 
leading to a decrease in its decomposition temperature.35 
Furthermore, as the graphitic domains were completely 
decomposed at 600°C, the residues above this temperature 
on the TGA curve could be related to the silver content on 
GO-Ag nanocomposite. The final residue was approximately 
50 wt%, thus implying that the mass ratio proportion of 
Ag:GO was approximately 1:1.
The presence of functional groups on the GO and GO-Ag 
surfaces was investigated using XPS, and the results are 
shown in Figure 2. For both nanomaterials, the C 1s signal 
was deconvoluted into three peaks (curve fitting was per-
formed using Gaussian and Lorentzian lineshapes), which 
correspond to C–C (C sp2 and C sp3, 285 eV), C–O (epoxy and 
hydroxyl, 287 eV), and C=O (carboxyl, 289 eV). After the 
decoration of the GO surface with AgNPs, the intensity 
Figure 1 Photographs of the gO and gO-ag dispersions (50 µg ml-1) (A). UV-vis absorption spectra of gO and gO-ag dispersions (B). XrD patterns of gO and gO-ag 
nanocomposite (C). Thermogravimetric curves of gO and gO-ag (D). 
Abbreviations: gO, graphene oxide; gO-ag, graphene oxide-silver nanocomposite; XrD, X-ray diffraction; UV-vis, ultraviolet-visible.
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related to the C–O signal decreased, whereas the intensity 
of the C–C signal was slightly increased.
It has been reported that GO undergoes chemical reduc-
tion by Na
3
C
6
H
5
O
7
, restoring π-conjugation within the gra-
phene sheets.32 However, the residual oxygenated groups 
on the GO-Ag nanocomposite surface were sufficient to 
maintain the colloidal stability of the nanocomposite in the 
aqueous dispersion in the current study. The Ag 3d core-level 
spectrum (Figure S1) of GO-Ag nanocomposite shows the 
binding energies of the Ag 3d
3/2
 and Ag 3d
5/2
 electronic states 
(368.4 and 374.4 eV, respectively), which also confirmed the 
formation of AgNPs on the GO surface. Therefore, the XRD 
and XPS results indicated the formation of metallic AgNPs 
on GO sheets.21,22 Additional characterization of GO and 
GO-Ag is available in the Figures S2–S4.
The morphological characteristics of both GO and 
GO-Ag nanocomposite were analyzed by TEM. A typical 
TEM image of GO exhibited a transparent and stable sheet 
(Figure 3A). After functionalization with the AgNPs, the 
TEM image clearly showed highly decorated GO-Ag sheets 
(Figure 3B). The spherical-like AgNPs were well-dispersed 
throughout the GO sheets and were exclusively attached to 
the material surface, demonstrating the strong interaction 
between the AgNPs and GO (Figure 3C). Figure 3D shows 
that the average size of AgNPs was 9.4±2.8 nm. The attach-
ment of AgNPs to the GO surface could be attributed to the 
interactions between Ag+ ions and the oxygen-containing 
groups on the GO sheets, which provide nucleation sites for 
anchoring and growth of AgNPs. The deposition of AgNPs 
may also be related to the adsorption of citrate anions on 
the GO surface via hydrogen bonding between functional 
groups of GO and the carboxyl and hydroxyl groups of cit-
rate. Thus, in the current study, the adsorbed citrate anions 
could have acted as nucleation sites for Ag+ ions, leading to 
a subsequent formation and stabilization of AgNPs on the 
GO surface.36 
antibacterial activity of gO and gO-ag: 
MIc, MBc, and time-kill curves
The antimicrobial properties of GO and GO-Ag nanocom-
posites were investigated against Gram-negative and Gram-
positive bacteria. The MIC and MBC values for several 
bacterial strains are shown in Table 1. The MIC of GO-Ag 
for MRSA was 15 µg mL-1, which was slightly lower than the 
30 µg mL-1 observed for non-MR S. aureus and E. faecalis. 
Moreover, the MIC of GO-Ag for MRSA was significantly 
lower than that presented by the conventional antibiotic oxa-
cillin (31 µg mL-1), as seen in Table 2. Among the bacterial 
strains evaluated, the Gram-negative A. baumannii demon-
strated the lowest MIC value of 6 µg mL-1 in the presence 
of GO-Ag nanocomposite.
These findings are noteworthy because these bacteria are 
nosocomial pathogens commonly associated with hospital-
acquired infections.3 We did not observe a direct correlation 
between the MIC and MBC values of Gram-positive and Gram-
negative bacteria. The MBC/MIC ratio offers information about 
the nature of the antibacterial activity. For example, when the 
MBC/MIC ratio is between 1 and 2, the sample is considered as 
a bactericidal agent. On the other hand, if the MBC/MIC ratio 
is higher than 2, the antimicrobial substance can be classified 
as a bacteriostatic agent.30 In our present study, MBC/MIC 
ratios indicate that, rather than a bacteriostatic effect, GO-Ag 
acted as a strong bactericidal agent. Furthermore, no toxicity 
was found for pristine GO, even at the highest concentration of 
60 µg mL-1 (Table 1). Additionally, pristine AgNPs exhibited 
MIC .80 µg mL-1 (Table 2). As a consequence, MIC and MBC 
values were not determined for pure GO and AgNP samples. 
Details regarding the synthesis of pristine AgNPs as well as 
Figure 2 c 1s XPs spectra of gO (A) and gO-ag (B). 
Abbreviations: XPs, X-ray photoelectron spectroscopy; gO, graphene oxide; gO-ag, graphene oxide-silver nanocomposite.
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their characterization are described in Supplementary materi als, 
“Synthesis of silver nanoparticles” section (Figures S5–S6).
To investigate the antibacterial kinetics of GO and GO-Ag 
nanocomposite, we conducted time-kill experiments using 
E. coli and MRSA as models for Gram-positive and Gram-
negative bacteria, respectively (Figure 4A, B). The time-kill 
curves for GO exhibited a similar trend compared to the 
control curve, which suggests that GO was not toxic to the 
Figure 3 TeM images of gO (A), and gO-ag sheets (B, C). size distribution of agNPs anchored to gO sheets (D). The size distribution was calculated by counting more 
than 500 nanoparticles in several gO-ag images, using ImageJ software.
Abbreviations: TeM, transmission electron microscopy; gO, graphene oxide; gO-ag, graphene oxide-silver nanocomposite; agNPs, silver nanoparticles.
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? ?
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??
?? ? ????????????????????????
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Table 1 Values of MIc and MBc for gO and gO-ag against gram-positive and gram-negative bacteria
Strain MIC (µg mL-1) MBC (µg mL-1) MBC/MIC
GO GO-Ag GO GO-Ag GO-Ag
Staphylococcus aureus N315 (Mrsa) .60 15 – 30 2
Staphylococcus aureus aTcc 29213 .60 30 – 30 2
Enterococcus faecalis aTcc 29212 .60 30 – 60 2
Escherichia coli aTcc 25922 .60 15 – 30 2
Acinetobacter baumannii aTcc 19606 .60 6 – 15 2.5
Salmonella enterica Typhimurium lT2 .60 30 – 60 2
Pseudomonas aeruginosa aTcc 27853 .60 15 – 30 2
Abbreviations: MIc, minimal inhibitory concentration; MBc, minimal bactericidal concentration; gO, graphene oxide; gO-ag, graphene oxide-silver nanocomposite; 
Mrsa, methicillin-resistant Staphylococcus aureus.
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bacterial strains at the concentration of 15 µg⋅mL-1. This 
observation is consistent with the MIC experiment reported in 
the “Evaluation of antibacterial activity” section. However, the 
time-kill curves show an effective antimicrobial effect for the 
GO-Ag sample at the MIC concentrations (15 µg mL-1 for both 
cultures). A significant decrease in the cellular viability was 
observed after 2 and 4 hours’ contact with E. coli and MRSA 
cells, respectively. Hence, the time-kill curves demonstrated 
the ability of GO-Ag to rapidly kill bacterial cells at a very low 
concentration. These results support the potential application 
of GO-Ag as an effective antimicrobial agent for the inactiva-
tion of relevant clinical pathogens such as MRSA. 
evaluation of morphological integrity 
of gO-ag-treated E. coli and  
Mrsa cells
The morphological changes in E. coli and MRSA cells 
resulting from exposure to GO-Ag nanocomposite were 
assessed by TEM. Untreated E. coli (Figure 5A, B) and 
MRSA (Figure 6A, B) exhibited normal rod-shaped and 
round-shaped morphologies, respectively, both with 
intact cell membranes. However, when both bacteria were 
treated with 15 µg mL-1 of GO-Ag, the cells lost their 
morphological integrity. E. coli cell walls and membranes 
were found to be partially disrupted (Figure 5C–E). In 
addition, a severely damaged E. coli cell exhibited leak-
age of intracellular contents, as shown by the arrows in 
Figure 5F. 
The cell walls and membranes of MRSA were also found 
to be disrupted (Figure 6C–F). An apparent decrease in 
cellular volume was also observed (Figure 6D, F; arrows). 
In general, it was possible to detect the intimate contact 
between the graphene sheets and the surface of the bacteria. 
In fact, some bacterial cells seemed to be wrapped by gra-
phene sheets, which likely favored the interaction between 
the AgNPs on GO-Ag nanocomposite and the bacterial sur-
faces (Figures 5C–F and 6C–F). It is worthy to note that the 
sample preparation, which involved centrifuging steps, may 
have also promoted the contact of GO-Ag nanocomposite 
with the bacterial cells.
Discussion
In the current study, we report the synthesis of GO functional-
ized with AgNPs using Na
3
C
6
H
5
O
7
 as a reducing agent. GO 
sheets were found to be decorated with spherical AgNPs with 
an average diameter of 9.4 nm. The bactericidal activity of 
GO and GO-Ag was investigated using several nosocomial 
bacterial strains as model microorganisms. Indeed, our 
present study was particularly focused on MRSA, because it 
is a microorganism that is resistant to a variety of antibiotics 
Figure 4 Time-kill curves of gram-negative Escherichia coli aTcc 25922 (A), and gram-positive Mrsa N315 (B). 
Note: error bars represent the standard deviations of three replicates (n=3).
Abbreviations: Mrsa, methicillin-resistant Staphylococcus aureus; h, hours; cFU, colony-forming units; gO, graphene oxide; gO-ag, graphene oxide-silver nanocomposite.
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Table 2 Values of MIc and MBc for oxacillin and agNPs against 
Mrsa and Escherichia coli as model microorganisms
MRSA E. coli
MIC  
(µg mL-1)
MBC  
(µg mL-1)
MIC  
(µg mL-1)
MBC  
(µg mL-1)
Oxacillin 31 62 500 2,000
agNPs .80 – .80 –
Abbreviations: MIc, minimal inhibitory concentration; MBc, minimal bactericidal 
concentration; agNPs, silver nanoparticles; Mrsa, methicillin-resistant Staphylococcus 
aureus.
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and is responsible for frequent cases of hospital-acquired 
infections.37
Furthermore, data regarding the antibacterial activity of 
silver-based graphene nanocomposite toward this multidrug-
resistant bacterium are scarce. Moreover, antimicrobial 
nanomaterials are unlikely to cause resistance in pathogen 
microorganisms, making them promising alternatives for 
overcoming infectious diseases.10 Due to their high sur-
face area and minimal risk to human health, AgNPs have 
emerged as an effective antimicrobial agent against several 
microorganisms.9,10,38,39 Indeed, graphene-based materials 
are biocompatible, which contributes to their usefulness as 
novel antimicrobial platforms.40,41 
The 15 µg mL-1 MIC of GO-Ag nanocomposite against 
MRSA cannot be fairly compared to other previous studies, 
because the toxicity of graphene-silver nanocomposite to this 
specific bacterial strain has not been reported in the literature 
yet. Prior studies have already investigated the antibacterial 
activity of pristine AgNPs toward MRSA. However, higher 
MIC values have been found for bare AgNPs compared to 
that observed for our homemade GO-Ag nanocomposite.42–44 
Ayala-Núñez et al44 reported that commercially obtained 
AgNPs had an MIC value of 1.8 mg mL-1 against MRSA. 
Similarly, AgNPs with different size distributions (from 
9 nm to 30 nm) displayed MIC values from 14.4 µg mL-1 
to 260 µg mL-1 against MRSA.42 
Figure 5 TeM images of Escherichia coli cells not exposed to gO-ag nanocomposite (A, B); and E. coli cells treated with 15 µg⋅ml-1 gO-ag for 2 h (C–F). The cell 
membranes were found to be disrupted after contact with gO-ag. The disruption of the bacterial cell and subsequent leaking of intracellular contents are highlighted by 
red arrows in C–F. 
Abbreviations: TeM, transmission electron microscopy; gO-ag, graphene oxide-silver nanocomposite; h, hours.
?????? ?????? ??????
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When compared to other previous studies, the present 
GO-Ag sample revealed an enhanced antibacterial activity. 
For instance, Liu et al45 showed that E. coli cells were inac-
tivated at a GO-Ag composite concentration of 80 µg mL-1. 
Shen et al24 demonstrated that Ag-chemically converted gra-
phene nanocomposite destroyed Colibacillus spp., S. aureus, 
and Candida albicans cells at a concentration of 50 µg mL-1. 
In addition, our GO-Ag nanocomposite showed almost identi-
cal toxic effects against either MRSA or non-MR S. aureus, 
which suggests the antibacterial activity of GO-Ag was not 
affected by the drug-resistance mechanisms of MRSA. In other 
words, the GO-Ag nanocomposite seemed to not suppress the 
expression of specific drug-resistance proteins, because both 
MRSA and non-MR strains were similarly inhibited by the 
Figure 6 TeM images of Mrsa cells not exposed to gO-ag nanocomposite (A, B); and Mrsa cells treated with 15 µg⋅ml-1 gO-ag for 2 h (C–F). The cell membranes were 
severely damaged after exposure to gO-ag. Visible damage on the cell surface is indicated by red arrows (C–F). 
Abbreviations: Mrsa, methicillin-resistant Staphylococcus aureus; TeM, transmission electron microscopy; gO-ag, graphene oxide-silver nanocomposite; h, hours. 
? ? ?
?? ?
??????
?????? ?????? ??????
?????? ??????
nanocomposite.44 Furthermore, GO-Ag was able to inactivate 
E. faecalis and A. baumannii (Table 1), two bacteria also 
frequently associated with nosocomial infections.46,47
Pristine AgNPs stabilized with citrate did not display 
inhibitory activity against either MRSA or E. coli at a 
concentration of 80 µg mL-1 (Table 2). This result is in 
accordance with various studies that have observed a loss 
of antibacterial activity for citrate-capped AgNPs.48–50 For 
instance, Taner et al50 described that bare citrate-AgNPs were 
not toxic to E. coli cells at a concentration of 150 µg mL-1, 
whereas silver–copper nanoalloys exhibited an MIC of 
0.5 µg mL-1. Additionally, many authors have reported that 
graphene-silver nanocomposite presented an improved anti-
bacterial activity compared to bare AgNPs.21,23,51–53 Tian et al53 
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for example, showed that 85.3% and 28% of viable S. aureus 
cells were inhibited by GO functionalized with iron oxide 
nanoparticles and AgNPs, and bare AgNPs, respectively. 
Ma et al21 also observed the growth of colonies after contact 
between E.coli and pristine AgNPs, while no colonies were 
visualized when the same bacteria was treated with silver-
modified GO. Finally, Xu et al23 reported that reduced GO 
decorated with AgNPs nanocomposite performed fourfold 
better than bare AgNPs, showing complete inhibition of 
E. coli cells at a concentration of 12.5 µg mL-1.
Except for the fact that E. coli cells underwent a more rapid 
inactivation mechanism, MRSA and E. coli presented very 
similar antibacterial kinetics in the presence of GO-Ag sheets. 
In fact, E. coli cells were found to be completely inactivated by 
GO-Ag approximately 2 hours earlier than MRSA cells. This 
observation may be related to the differences in the cellular 
wall structure between Gram-negative and Gram-positive 
bacteria. Gram-positive MRSA has a thicker peptidoglycan 
layer that may provide improved physical protection against 
the biocidal effects of GO-Ag nanocomposite.33
Although some studies have attributed antimicrobial 
activity to pristine GO sheets,40,41,54,55 our GO sample did not 
display toxicity to the bacterial strains at the range of con-
centrations investigated. These contradictory results might 
be related to the distinctive physicochemical properties of 
each graphene-based sample, such as surface area, oxidation 
degree, thickness and lateral dimensions of sheets, carbon 
precursor source, and purity.56 Therefore, further investiga-
tion is needed to elucidate the correlation between the most 
relevant physicochemical properties of GO sheets and their 
possible antibacterial activity. Our result is consistent with 
other previous studies that have reported no toxicity for GO 
nanosheets against bacterial cells.19,57
Despite the abundant studies19–25 regarding the antibac-
terial activity of GO-Ag nanocomposite, the mechanism of 
toxicity of this nanomaterial is not completely understood. 
However, AgNPs may be considered the major contributor 
to the antibacterial effect of GO-Ag, and their inhibitory 
effect can be a combination of several mechanisms. Mostly, 
AgNPs are able to release Ag+ ions, which possess great 
affinity for the thiol groups of enzymes and proteins. These 
interactions between silver ions and the sulfur-containing 
functional groups of proteins can lead to losses in membrane 
permeability, inhibition of the respiratory chain, and deac-
tivation of essential cellular components such as DNA.58,59 
The antibacterial activity may also be caused by the direct 
contact between GO-Ag sheets and the bacterial cell surface. 
As a consequence, the extraction of phospholipids and severe 
damage to the membrane and cellular walls may be possible.60 
In addition, GO-Ag nanocomposite is likely able to deploy 
its toxicity through oxidative stress mechanisms. Therefore, 
microbial cells can be inactivated by reactive oxygen species 
generated by AgNPs under aerobic conditions.61–64 Some stud-
ies have hypothesized that the enhanced antibacterial45 activ-
ity of the graphene-silver nanocomposite might be a result of 
a synergistic effect between GO sheets and AgNPs.23 Then, 
GO sheets would provide a large surface area for bacterial 
attachment, thus allowing a more intimate contact between 
the AgNPs and the surface of bacterial cells.19,25,51–53
In our current study, the most likely antimicrobial mecha-
nism for the GO-Ag nanocomposite might be related to the 
release of Ag+ ions and the direct contact of bacterial cells 
with the AgNPs attached to the GO surface. As observed by 
TEM analysis, GO-Ag sheets are accumulated around the 
bacterial cell surfaces (Figures 5C–F and 6C–F). Despite the 
fact that both GO-Ag and bacteria have negatively charged 
surfaces, hydrogen bonding between the oxygenated groups 
present on GO-Ag sheets and the proteins of the cell mem-
branes facilitates the direct contact of GO-Ag sheets with 
the bacterial cells. The wrapping of GO-Ag sheets around 
the microbial cells could eventually block the cells’ access 
to nutrients and could induce cell death.21 Indeed, MRSA 
and E. coli cell walls and membranes became disordered 
and fragmented (Figures 5C–F and 6C–F). The formation of 
pits and holes in the membrane upon contact with GO-Ag 
nanocomposite might increase cell permeability, thus allow-
ing the leakage of cytoplasmic fluids and further cellular 
inactivation.59,64,65
To the best of our knowledge, our present study adds 
some novelty to this field, because this is the first report con-
cerning the use of a graphene-based nanocomposite against 
the drug-resistant bacteria MRSA. We believe that further 
efforts are still needed to better clarify the antibacterial 
mechanisms of GO-Ag at the molecular level. Nevertheless, 
our findings represent a step forward in the understanding of 
how graphene-based nanocomposites interact with microor-
ganisms. Furthermore, the results presented herein may sup-
port the use of GO-Ag as an effective antimicrobial agent to 
prevent bacterial contamination in clinical facilities.
Conclusion
In summary, we reported a straightforward and fea-
sible method to synthesize GO-Ag nanocomposite using 
Na
3
C
6
H
5
O
7
 as a reducing agent. The results showed that GO 
sheets were decorated with spherical AgNPs with an average 
diameter of 9.4 nm. The AgNPs were highly dispersed 
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throughout the GO sheets and were exclusively supported 
on the material surface. The GO-Ag nanocomposite pre-
sented broad-spectrum antibacterial activity against bacteria 
commonly found in hospital environments, such as E. coli, 
E. faecalis, A. baumannii, and the antibiotic-resistant MRSA. 
However, no toxicity was observed for pristine GO (up to 
60 µg mL-1) or for bare citrate-AgNPs (up to 80 µg mL-1). 
Regarding the antibacterial kinetics, 100% of MRSA cells 
were inactivated after 4 hours’ contact with GO-Ag, while E. 
coli cells were completely inactivated approximately 2 hours 
earlier. TEM images revealed morphological changes to 
E. coli and MRSA cells resulting from direct contact with 
GO-Ag nanocomposite. The images showed that GO-Ag 
sheets accumulated around the bacterial cell surfaces, thus 
leading to cell inactivation. These results support substan-
tial evidence for how GO-Ag nanocomposite interacts with 
MRSA and E. coli cells, indicating that GO-Ag is a promising 
antibacterial agent for biomedical applications.
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Figure S5 UV-vis absorption spectrum of bare agNPs.
Abbreviations: UV-vis, ultraviolet-visible; agNPs, silver nanoparticles.
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Figure S2 XPs survey spectra of gO and gO-ag nanocomposite.
Note: (c 1s-carbon and O 1s-oxygen).
Abbreviations: XPs, X-ray photoelectron spectroscopy; gO, graphene oxide.
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Figure S1 ag 3d XPs spectrum of gO-ag nanocomposite.
Abbreviations: XPs, X-ray photoelectron spectroscopy; gO, graphene oxide.
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Figure S3 FTIr spectra of gO and gO-ag nanocomposites.
Abbreviations: FTIr, Fourier transform infrared; gO, graphene oxide.
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Figure S4 raman spectra of gO and gO-ag nanocomposites.
Abbreviation: gO, graphene oxide.
synthesis of silver nanoparticles
The silver nanoparticles (AgNPs) were produced by the 
Turkevich method using sodium citrate as the reducing/
stabilizing agent. For this procedure, 8.4 mg of AgNO
3
 
was dissolved in 40 mL of deionized water. This solution 
was transferred to a two-neck round-bottom flask and 
heated at reflux. As soon as it began to boil, 10 mL of a 
1.0×10-3 mol L-1 sodium citrate solution was added dropwise. 
The reaction was maintained at 130°C for 30 minutes. The 
color of the solution slowly turned yellow–green, indicating 
the formation of the AgNPs. The AgNPs were dialyzed for 
a few hours to remove residual salts (Fisherbrand dialysis 
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Figure S6 (A) and (B), TeM images of bare agNPs. (C) Particle size distribution of agNPs. The size distribution was calculated by counting more than 500 nanoparticles in 
several agNP images, using ImageJ software.
Abbreviations: TeM, transmission electron microscopy; agNPs, silver nanoparticles.
tubing, 12,000–14,000 Da) and were stored in a sealed vessel 
protected from light. 
The formation of AgNPs was confirmed through the 
plasmon absorption band at 420 nm (UV-Vis, Shimadzu 
UV-1650PC spectrometer), and the morphology of the 
AgNPs was observed by TEM (Zeiss LIBRA 120 micro-
scope, accelerating voltage of 120 kV). 
